Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/195"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"evidence_1915"
|
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:content |
"Metabolism and elimination �
...
Atomoxetine is excreted primarily as 4�hydroxyatomoxetine-O-glucuronide, mainly in the urine (greater than 80% of the dose) and to a lesser extent in the feces (less than 17% of the dose). Only a small fraction of the STRATTERA dose is excreted as unchanged atomoxetine (less than 3% of the dose), indicating extensive biotransformation."
|
| dc:creator | |
| dc:date |
"09/24/2009 11:13:31"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ atomoxetine_primary_total_clearance_mechanism_Metabolic_Clearance, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1915 }